Current Report Filing (8-k)
July 05 2013 - 4:51PM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C.
20549
________________
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of The Securities Exchange
Act of 1934 Date of Report (Date of earliest event reported): July 5,
2013
MINDESTA INC.
(Exact name of registrant as specified in its charter)
Delaware |
11-3763974 |
(State or other jurisdiction of incorporation) |
(IRS Employer Identification No.)
|
Suite 201, 290 Picton Avenue, Ottawa, Ontario, Canada
K1Z 8P8
(Address of principal executive offices) (Zip Code)
Registrants telephone number, including area code:(613)
241-9959
Former name or former address, if changed since last report:
Not applicable
Check the appropriate box below if the Form 8-K filing is
intended to simultaneously satisfy the filing obligation of the registrant under
any of the following provisions (See General Instruction A.2 below):
[ ] |
Written communications pursuant to Rule 425 under the
Securities Act (17 CFR 230.425) |
|
|
[ ] |
Soliciting material pursuant to Rule 14a-12 under the
Exchange Act (17 CFR 240.14a-12) |
|
|
[ ] |
Pre-commencement communications pursuant to Rule 14d-2(b)
under the Exchange Act (17 CFR 240.14d-2(b)) |
|
|
[ ] |
Pre- commencement communications pursuant to Rule
13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
|
Item 5.02. Departure of Directors or Principal Officers.
Efffective July 5, 2013, W. Campbell Birge, Douglas Perkins,
and Albert Zapanta resigned as Directors of Mindesta Inc.. There were no
disagreements with the Company regarding its operations or financial reporting.
- 2 -
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of
1934, the registrant has duly caused this report to be signed on its behalf by
the undersigned thereunto duly authorized.
|
MINDESTA INC. |
|
|
|
|
|
|
Date: July 5, 2013 |
|
|
By: /s/ Gregory
Bowes
|
|
Name: Gregory B. Bowes |
|
Title: Chief Executive Officer and Chief
Financial Officer |
- 3 -
CTT Pharmaceutical (PK) (USOTC:CTTH)
Historical Stock Chart
From Jun 2024 to Jul 2024
CTT Pharmaceutical (PK) (USOTC:CTTH)
Historical Stock Chart
From Jul 2023 to Jul 2024